Chairs

  • Emily Breidbart
  • Sowmya Krishnan

BOD Liaison

Laurie Cohen

Charged with keeping the Society informed on topics about both new and existing drugs and devices. To review problems related to the therapeutics of Pediatric Endocrine disorders and report to the Board of Directors and the greater membership of PES.

New Meds and Tech from PES Drugs and Therapeutics Committee Evolocumab
January 26, 2022

EVOLOCUMAB (REPATHA) Brenda Kohn MD, Dania Al-Hamad MD, Ambika P.…

New Ready-to-Use Glucagon Preparation: Zegalogue
December 14, 2021

Prepared on behalf of the PES Drugs and Therapeutics Committee…

New Meds and Tech from PES Drugs and Therapeutics Committee
August 27, 2021

Brief Therapeutic Update from PES Drugs and Therapeutics Committee (THYQUIDITYTM)…